Immune Globulin Subcutaneous Articles
CSL Behring enters deal for Canada
14 April 2008
ZLB Behring's Vivaglobin approved in UK
1 May 2006
FDA approves ZLB Behring's Vivaglobin for PIDD
16 January 2006
Showing 1-4 of 4 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
